Red blood cell exchange to avoid intubating a COVID-19 positive patient with sickle cell disease?
Acute Chest Syndrome
/ etiology
Adult
Analgesics
/ therapeutic use
Anemia, Sickle Cell
/ complications
Antiviral Agents
/ therapeutic use
Azithromycin
/ therapeutic use
Betacoronavirus
COVID-19
Combined Modality Therapy
Contraindications, Procedure
Coronavirus Infections
/ complications
Erythrocyte Transfusion
/ methods
Humans
Hydroxychloroquine
/ therapeutic use
Intubation, Intratracheal
Male
Methylprednisolone
/ therapeutic use
Oxygen Inhalation Therapy
Pandemics
Pneumonia, Viral
/ complications
Respiration, Artificial
Respiratory Insufficiency
/ etiology
SARS-CoV-2
HbSC
SARS-CoV-2
acute chest syndrome
Journal
Journal of clinical apheresis
ISSN: 1098-1101
Titre abrégé: J Clin Apher
Pays: United States
ID NLM: 8216305
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
28
04
2020
revised:
15
06
2020
accepted:
16
06
2020
pubmed:
7
7
2020
medline:
22
8
2020
entrez:
7
7
2020
Statut:
ppublish
Résumé
As the COVID-19 pandemic continues to claim lives across the globe, insufficient data exists regarding the optimal treatment. It is well known that patients 55 years of age or older and patients with certain chronic diseases are at higher risk of severe illness, including acute respiratory distress syndrome and death. A potentially fatal pulmonary complication of sickle cell disease, acute chest syndrome, can be precipitated by acute infections, including respiratory viruses. We report the case of a patient with sickle cell disease (HbSC) who developed COVID-19 pneumonia and acute chest syndrome who was treated with emergent red blood cell exchange in order to avoid endotracheal intubation.
Identifiants
pubmed: 32629539
doi: 10.1002/jca.21809
pmc: PMC7361739
doi:
Substances chimiques
Analgesics
0
Antiviral Agents
0
Hydroxychloroquine
4QWG6N8QKH
Azithromycin
83905-01-5
Methylprednisolone
X4W7ZR7023
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
378-381Subventions
Organisme : NHLBI NIH HHS
ID : K08 HL133474
Pays : United States
Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
JAMA. 2014 Sep 10;312(10):1033-48
pubmed: 25203083
Eur J Haematol. 2011 Sep;87(3):191-207
pubmed: 21615795
Indian J Pediatr. 2020 Apr;87(4):281-286
pubmed: 32166607
Am J Hematol. 2020 Jul;95(7):E154-E156
pubmed: 32243621
AJR Am J Roentgenol. 2020 Jun;214(6):1280-1286
pubmed: 32130038
J Clin Apher. 2020 Aug;35(4):378-381
pubmed: 32629539
Br J Haematol. 2020 Jun;189(5):851-852
pubmed: 32314798
Crit Care. 2020 Mar 16;24(1):91
pubmed: 32178711